Disease Areas

Sanofi Ends Development of Breast Cancer Drug Amcenestrant

Invivoscribe, Kronos Bio Partner on Companion Diagnostic Test for Leukemia Drug

Gilead Sciences Files for Trodelvy FDA Approval in HR-Positive Breast Cancer, Buys Rights in Asia

Anixa Biosciences Doses First Ovarian Cancer Patient in Novel Autologous Cell Therapy Trial

AstraZeneca, Daiichi Sankyo's Enhertu Scores FDA Accelerated Approval in HER2-Mutant Lung Cancer

Novartis' Tabrecta Nets Full FDA Approval for NSCLC With METex14 Skipping Mutations

Roche Nabs FDA Label Expansion for Ventana CDx Panel

Bristol Myers Squibb, 2seventy Bio Eyeing Earlier-Line Multiple Myeloma Abecma Indication

VolitionRx, MD Anderson Cancer Center Partner to Study Cancer Patients With Sepsis

Mount Sinai Using $500K Grant to Study KRAS-Mutant Lung Cancer Treatments

GSK, Mersana Therapeutics Ink $100M Option Agreement for Antibody-Drug Conjugate

Immuno-Genomic Features Predict Treatment Response in Esophageal Carcinoma

Small Cell Lung Cancer Detection, Classification Achieved Using Cell-Free DNA Methylation

Alercell to Distribute Amoy Diagnostic Ros1 Gene Fusion Detection Kit in US

Chronic Lymphocytic Leukemia Genomic Study Reveals New Subtypes, Ties to Outcomes